In a newly developed preclinical NASH–HCC model with C57/BL6NJ mice, H19 is in the top ten upregulated genes (GSE197884) (Fig. 4c) [32]. This evidence concerns the gene H19 and metabolic dysfunction-associated steatohepatitis.